News

Abry Partners has recapitalized Phoenix-based Anju Software Inc, a provider of software and data services for the life science sector. No financial terms were disclosed.

PRESS RELEASE

PHOENIX, March 4, 2019 /PRNewswire/ — Anju Software Inc., a Phoenix-based provider of software and data services to the life science industry, has completed a recapitalization with Abry Partners, a Boston-based private equity firm. Abry’s investment will provide capital for continued product enhancement and global expansion and position Anju for market leadership in the life sciences software industry.

Kurien Jacob, Anju’s Chief Executive Officer, commented, “the Anju team has worked with Abry before and appreciate their track record of providing capital and strategic advice for companies like Anju to grow organically and through acquisitions.”

Founded in 1989, Abry Partners has since proven their ability to succeed by becoming one of the premier sector-focused private equity investment firms in North America, with numerous investments in the life sciences and software & data industries. Their investment in Anju adds a seasoned and proven life science software and actionable data provider to their expanding portfolio.

“Abry believes that connecting the data from molecule to retirement using actionable software will become an essential part of the life science ecosystem and Anju is well positioned to provide this connection,” said Tyler Wick, Partner with Abry. “We are excited to partner with Anju to accelerate their efforts to become one of the premier global life sciences software and data platforms.”

About Anju Software
Anju Software is a leading provider of comprehensive software and data solutions to the life sciences industry. Anju provides an integrated platform spanning clinical, medical affairs and commercial operations. Anju has combined deep industry and software domain expertise to build a next generation platform for the life sciences sector that can scale to provide solutions that meet customers’ needs from “molecule to retirement.” Anju solutions are used by large and small pharmaceutical companies, clinical research organizations (CROs), full service agencies and medical device companies. Data flow between functional areas, seamless communication with third party systems and AI-based data mining solutions provide a unique way for Anju customers to leverage critical information throughout their ecosystem. For more information, please visit www.anjusoftware.com.

About Abry Partners
Abry is one of the most experienced and successful sector-focused private equity investment firms in North America. Since their founding in 1989, the firm has completed over $80 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5.0 billion of capital across their active funds.